Table Of Contents:

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	22
2.2 Major Growth Drivers	24
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of North America Market by Test	41
3.1 Market Overview by Test	41
3.2 Lipid Panel	43
3.3 Infectious Disease Testing	44
3.4 Liver Panel	45
3.5 Complete Blood Count (CBC)	46
3.6 Electrolyte Testing	47
3.7 Renal Panel	48
3.8 Other Tests	49
4 Segmentation of North America Market by Product	50
4.1 Market Overview by Product	50
4.2 Instruments	52
4.3 Assay Kits & Reagents	53
4.4 Software & Services	54
5 Segmentation of North America Market by Indication	55
5.1 Market Overview by Indication	55
5.2 Cardiovascular	57
5.3 Cancer	58
5.4 Infectious Disease	59
5.5 Stroke	60
5.6 Chronic Lower Respiratory Diseases	61
5.7 Diabetes	62
5.8 Other Indications	63
6 Segmentation of North America Market by Patient Gender	64
6.1 Market Overview by Patient Gender	64
6.2 Male Patients	66
6.3 Female Patients	67
7 Segmentation of North America Market by Age Group	68
7.1 Market Overview by Age Group	68
7.2 Age 44 and below	70
7.3 Age 45-64	71
7.4 Age 65 and over	72
8 Segmentation of North America Market by End User	73
8.1 Market Overview by End User	73
8.2 Hospital & Clinics Laboratory	75
8.3 Diagnostic Laboratory	76
8.4 Point-of-Care Testing	77
8.5 Other End Users	78
9 North America Market 2021-2031 by Country	79
9.1 Overview of North America Market	79
9.2 U.S.	82
9.3 Canada	86
9.4 Mexico	88
10 Competitive Landscape	90
10.1 Overview of Key Vendors	90
10.2 New Product Launch, Partnership, Investment, and M&A	93
10.3 Company Profiles	94
Abbott Laboratories	94
Becton, Dickinson and Company	96
BioMerieux SA	97
Bio-Rad Laboratories Inc.	98
Bio-Reference Laboratories	99
Bioscientia Healthcare	100
Charles River Laboratories	101
Danaher Corporation	102
Hoffmann-La Roche AG	103
Hologic Inc.	104
Qiagen NV	105
Siemens Healthcare	106
Thermo Fisher Scientific	107
RELATED REPORTS	108

List Of Tables:
Table 1.  Snapshot of North America Clinical Diagnostics Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Health Spending by Region, $ bn, 2013-2020	29
Table 4.  Main Product Trends and Market Opportunities in North America Clinical Diagnostics Market	33
Table 5. North America Clinical Diagnostics Market by Test, 2021-2031, $ mn	41
Table 6. North America Clinical Diagnostics Market by Product, 2021-2031, $ mn	50
Table 7. North America Clinical Diagnostics Market by Indication, 2021-2031, $ mn	55
Table 8. North America Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn	64
Table 9. North America Clinical Diagnostics Market by Age Group, 2021-2031, $ mn	68
Table 10. North America Clinical Diagnostics Market by End User, 2021-2031, $ mn	73
Table 11. North America Clinical Diagnostics Market by Country, 2021-2031, $ mn	80
Table 12. U.S. Clinical Diagnostics Market by Test, 2021-2031, $ mn	85
Table 13. U.S. Clinical Diagnostics Market by Product, 2021-2031, $ mn	85
Table 14. U.S. Clinical Diagnostics Market by Indication, 2021-2031, $ mn	85
Table 15. Canada Clinical Diagnostics Market by Test, 2021-2031, $ mn	87
Table 16. Canada Clinical Diagnostics Market by Product, 2021-2031, $ mn	87
Table 17. Canada Clinical Diagnostics Market by Indication, 2021-2031, $ mn	87
Table 18. Mexico Clinical Diagnostics Market by Test, 2021-2031, $ mn	89
Table 19. Mexico Clinical Diagnostics Market by Product, 2021-2031, $ mn	89
Table 20. Mexico Clinical Diagnostics Market by Indication, 2021-2031, $ mn	89
Table 21. Abbott Laboratories: Company Snapshot	94
Table 22. Abbott Laboratories: Business Segmentation	95
Table 23. Abbott Laboratories: Product Portfolio	95

List Of Figures:
Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. North America Clinical Diagnostics Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	22
Figure 6. Primary Drivers and Impact Factors of North America Clinical Diagnostics Market	24
Figure 7.  Leading Causes of Death in the World, 2019-2020, million	27
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060	28
Figure 10. Primary Restraints and Impact Factors of North America Clinical Diagnostics Market	30
Figure 11. Investment Opportunity Analysis	34
Figure 12. Porter’s Fiver Forces Analysis of North America Clinical Diagnostics Market	37
Figure 13. Breakdown of North America Clinical Diagnostics Market by Test, 2021-2031, % of Revenue	42
Figure 14. North America Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%)	42
Figure 15. North America Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn	43
Figure 16. North America Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn	44
Figure 17. North America Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn	45
Figure 18. North America Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn	46
Figure 19. North America Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn	47
Figure 20. North America Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn	48
Figure 21. North America Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn	49
Figure 22. Breakdown of North America Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue	51
Figure 23. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)	51
Figure 24. North America Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn	52
Figure 25. North America Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn	53
Figure 26. North America Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn	54
Figure 27. Breakdown of North America Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue	56
Figure 28. North America Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%)	56
Figure 29. North America Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn	57
Figure 30. North America Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn	58
Figure 31. North America Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn	59
Figure 32. North America Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn	60
Figure 33. North America Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn	61
Figure 34. North America Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn	62
Figure 35. North America Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn	63
Figure 36. Breakdown of North America Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue	65
Figure 37. North America Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%)	65
Figure 38. North America Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn	66
Figure 39. North America Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn	67
Figure 40. Breakdown of North America Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue	69
Figure 41. North America Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%)	69
Figure 42. North America Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn	70
Figure 43. North America Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn	71
Figure 44. North America Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn	72
Figure 45. Breakdown of North America Clinical Diagnostics Market by End User, 2021-2031, % of Revenue	73
Figure 46. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	74
Figure 47. North America Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn	75
Figure 48. North America Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn	76
Figure 49. North America Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn	77
Figure 50. North America Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	78
Figure 51. Breakdown of North America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue	80
Figure 52. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	81
Figure 53. U.S. Clinical Diagnostics Market, 2021-2031, $ mn	83
Figure 54. Percent Distribution of the 10 Leading Causes of Death by Gender in United States, 2019, %	83
Figure 55. Percent Distribution of the 10 Leading Causes of Death by Age Group in United States, 2019, %	84
Figure 56. Canada Clinical Diagnostics Market, 2021-2031, $ mn	86
Figure 57.  Clinical Diagnostics Market in Mexico, 2021-2031, $ mn	88
Figure 58. Growth Stage of North America Clinical Diagnostics Industry over the Forecast Period	90

Selected Key Players: 
•	Abbott Laboratories
•	Becton, Dickinson and Company
•	BioMerieux SA
•	Bio-Rad Laboratories Inc.
•	Bio-Reference Laboratories
•	Bioscientia Healthcare
•	Charles River Laboratories
•	Danaher Corporation
•	Hoffmann-La Roche AG
•	Hologic Inc.
•	Qiagen NV
•	Siemens Healthcare
•	Thermo Fisher Scientific 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)